港股異動 | 阿里健康(0241.HK)漲超5% 股價再創新高
格隆匯6月23日丨阿里健康(0241.HK)現報23.1港元,漲幅5.24%,最新總市值2991.5億港元;盤中最高見23.2港元再創歷史新高。北京市委宣傳部副部長徐和建介紹,核酸檢測是精準防控的重要環節。要爭分奪秒、主動出擊,進一步提升檢測能力,擴大檢測範圍,做到應檢盡檢、願檢盡檢。近日,自北京市通報西城區有確診病例以來,通過天貓/支付寶購買的核酸檢測增長近10倍。618期間,天貓醫藥合作商家備貨充足,阿里健康自營大藥房全國多倉直髮,均可保證用户購買各類健康產品的時效性。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of this article is for reference only. It does not constitute an offer, solicitation, recommendation, opinion or guarantee of any securities, financial products or instruments.The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance.